Spirulina Scaffolds for Disease Treatment, Patent Filed
Summary
James Michael Roberts, Nhi Yen Khuong, Mesfin Mulugeta Gewe, and Benjamin Jester filed USPTO patent application US20260109742A1 on December 16, 2025 for recombinant Spirulina expressing scaffolds comprising heterologous moieties. The application covers methods of using these scaffolds for the treatment of diseases and conditions, classified under CPC codes C07K 14/47, C12N 15/74, A61K 38/00, and C07K 2319/30.
“The present disclosure provides scaffolds comprising heterologous moieties and Spirulina expressing the same.”
About this source
USPTO classification C07K covers peptides: short amino-acid chains that form the backbone of antibodies, hormones, vaccines, and increasingly a wider class of therapeutic modalities. Every newly published application in C07K lands in this feed, around 175 a month. Applications publish 18 months after filing, so this feed reveals what antibody engineering groups, vaccine developers, and plant biotech researchers were working on in the prior year and a half. Watch this if you compete in biologics, file freedom-to-operate analyses on antibody drug candidates, scout acquisition targets in vaccine platforms, or track protein-based agricultural biotech filings.
What changed
A new USPTO patent application has been published for recombinant Spirulina expressing scaffolds comprising heterologous moieties, with methods of utilizing the same for disease treatment. The application names four inventors and covers the use of Spirulina as a bio-manufacturing platform for scaffold expression.
Entities in the biotechnology and pharmaceutical sectors developing therapeutic platforms using algae-based expression systems should review this filing to assess potential freedom-to-operate considerations or licensing opportunities.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
RECOMBINANT SPIRULINA EXPRESSING SCAFFOLDS AND METHODS OF UTILIZING THE SAME
Application US20260109742A1 Kind: A1 Apr 23, 2026
Inventors
James Michael ROBERTS, Nhi Yen KHUONG, Mesfin Mulugeta GEWE, Benjamin JESTER
Abstract
The present disclosure provides scaffolds comprising heterologous moieties and Spirulina expressing the same. Also provided are recombinant Spirulina expressing scaffolds and methods of utilizing the same for the treatment of diseases and conditions.
CPC Classifications
C07K 14/47 C12N 15/74 A61K 38/00 C07K 2319/30
Filing Date
2025-12-16
Application No.
19422077
Mentioned entities
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.